Poland’s Chief Pharmaceutical Inspector, Łukasz Pietrzak, has responded to a report by Wirtualna Polska detailing a dangerous and fraudulent cancer treatment. The report highlighted the case of a woman named Anna, who was receiving intravenous infusions of a paint solvent falsely presented as cancer therapy for ovarian cancer. Pietrzak’s response was to advocate for the implementation of a so-called “lex szarlatan” – a law specifically targeting fraudulent practitioners and unproven therapies. He stated this case exemplifies the necessity for stricter regulations and harsher penalties against individuals offering dangerous and unscientific treatments. This incident raises serious concerns about patient safety and the vulnerability of individuals seeking alternative cancer treatments. The Inspector’s comments underscore the urgent need for legal frameworks to protect patients from exploitation and harm. Authorities are likely to investigate the individuals responsible for administering this harmful treatment.